Abstract PD13-01: PD13-01 Elacestrant in postmenopausal women with estrogen receptor positive and HER2-negative early breast cancer: primary efficacy and safety analysis of the preoperative, window of opportunity SOLTI-1905-ELIPSE trialMaría Vidal, Meritxell Bellet Ezquerra, Montserrat Muñoz-Mateu et al.|Cancer Research|2023Cited by 12
Abstract P2-10-18: A study to evaluate the safety and efficacy of vosilasarm (EP0062), an oral SARM, as monotherapy and in combination with standard of care regimens in patients with relapsed locally advanced or metastatic AR+/HER2-/ER+ breast cancerJoyce O’Shaughnessy, Hyo S. Han, Erika Hamilton et al.|Clinical Cancer Research|2025Cited by 0